Jointown Pharmaceutical (600998.SS) Trading Overview (as of 21 Oct 2026)
- Trading performance: The share price remained unchanged (0 %) during the 24‑hour period ending at 04:54 PM Central Europe on Wednesday, 21 Oct 2026.
- Price: One share can currently be purchased for approximately CNY 5 on major exchanges.
- Market capitalisation: CNY 25.2 bn.
- Trading volume: About CNY 123.7 mn worth of shares were traded in the last 24 hours.
- Supply: 5 bn shares are currently available on the market.
- Recent trend: Since the end of last month, the share price has fallen by 0.8 %.
- Technical indicators:
- Simple moving average (200 days): CNY 4.96
- 52‑week high: CNY 5.84 (23 Jan 2026)
- 52‑week low: CNY 4.48 (29 Jun 2026)
Recent Corporate Development
Jointown Pharmaceutical announced that it has completed its corporate registration and charter filing. The filing confirms compliance with all regulatory requirements and provides stakeholders with the latest administrative status. The announcement does not disclose any operational or financial details beyond the completion of the legal procedures. This development may improve transparency and strengthen investor confidence.
Performance of Related Stocks (Last 24 Hours)
| Symbol | Trading Result | Current Price | Market Capitalisation | P/E Ratio |
|---|---|---|---|---|
| Wuxi Lead Intelligent Equi‑h (0470.HK) | Up 1.64 % | HKD 19.06 | HKD 35.3 bn | 28.68 |
| Imeik Developme (300896.SZ) | Flat 0 % | CNY 95.4 | CNY 29.9 bn | 25.44 |
| Olympic Circuit (603920.SS) | Flat 0 % | CNY 40.9 | CNY 30 bn | 78.02 |
| Hainan Airport Infrastruct (600515.SS) | Flat 0 % | CNY 2.63 | CNY 30 bn | 142.62 |
| Chongqing Zhifei Biologica (300122.SZ) | Flat 0 % | CNY 12.74 | CNY 29.9 bn | — |
Additional Context:
- The Shanghai Composite Index fell slightly on 21 Oct 2026, and the beauty‑care sector recorded a modest decline with a net capital outflow of roughly 2.3 million yuan.
- A subsequent development involved a major industrial investor purchasing an initial tranche of ten thousand shares in a listed biomed‑device firm, including a conditional cash‑donation clause and a multi‑year lock‑up period. This arrangement indicates a long‑term commitment to support the company’s platform expansion.
Company Background
Jointown Pharmaceutical Group Co Ltd is a health‑care company headquartered in Hubei, China. Its product portfolio includes antibiotics, respiratory medications, cardiovascular drugs, vitamin tablets, health‑care drugs, and related medical instruments. The company listed on the Shanghai Stock Exchange on 2 Nov 2010. More information about its offerings is available on its website at www.jzteyao.com.cn .
